In the Hunt: A Headache for Small Drug Makers
1011
The F.D.A. has begun to crack down on the thousands of drugs, often made by small companies, that have never had to go through the agencyâs stringent approval process.
100064
Research and development costs drag down the drug developer's bottom line.
416882
Competition for painkiller patch may prove to be a major pain for the generics maker.
724808
An investigation into the practice of Internet Pharmacies and how they are changing the U.S. pharmaceutical industry.
511170
Now might be a great time to load up on cutting-edge drugmakers.
3117
India and China, countries where the Food and Drug Administration rarely conducts quality-control inspections, have become major suppliers of low-cost drugs and drug ingredients to American consumers. Analysts say their products are becoming pervasive in the generic and over-the-counter marketplace.
138928
Misaligned incentives are leading two potentially life-saving drugs for treating lymphoma to go underused.
31450
From production plant to pharmacy, some of the most sought-after drugs will now be tracked by the technology in tiny microchips. It&#39;s already getting the green light from law enforcement.
226313
Virtually every large drug maker is working to develop Alzheimerâs drugs, seeking to improve treatment and possibly snare a big financial payoff.
468484
Importing cheaper drugs from up north isn't as simple as it seems
493722
This pilot fish works for a small company that makes accounting software for a niche vertical market -- and one of its small customers has what seems to be a big problem.
147168
The approval of a new drug is a long-term opportunity.
271953
In a recent trial, a pain medication wasn't as effective as had been hoped.
259812
The pharmaceutical enlists help to thwart a troublesome illness.
33718
Will the drugmaker's hefty R&D bill pay off?
271921
The reduction in patients for Amylin's Byetta diabetes drug could be small.
268759
The larger pharmaceutical drops out of daclizumab development.